Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Aurinia reports favourable assessment of LUPKYNIS in ICER

pharmaceutical-technologyMarch 18, 2021

Tag: Aurinia , IPHAF , LUPKYNIS , ICER

PharmaSources Customer Service